← Back to Influence Map
Entity DossierOrganization
TAKEDA PHARMACEUTICALS AMERICA, INC.
DC · US
Pharmaceutical company.
pharmaceuticals
Tracked direct giving
$0
Tracked donations to candidate
$0
LDA reported lobbying spend
$220,000
Connections
5
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
MMMMedicare/Medicaid
$400KTAXTaxation/Internal Revenue Code
$290KCPTCopyright/Patent/Trademark
$290KTRDTrade
$290KHCRHealth Issues
$290KBUDBudget/Appropriations
$290KLobbying Firms Retained
CROSSROADS STRATEGIES, LLC$290K
TIBER CREEK GROUP$110K
Bills Referenced in Lobbying Filings
march-in
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Employed by | TIBER CREEK GROUP | Hired TIBER CREEK GROUP to lobby on Pharmaceuticals | Source |
| Employed by | CROSSROADS STRATEGIES, LLC | Hired CROSSROADS STRATEGIES, LLC to lobby on NIH March-In Rights | Source |
| Lobbied for | MARCH-IN Rights Proposal (NIH Framework) | LDA filing: lobbied on NIH March-In Rights, period 1st Quarter (Jan 1 - Mar 31), reported amount $40,000 | Source |
| Lobbied for | Sugar Reform Act (S.832, 118th Congress) | LDA filing: lobbied on Sugar Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $490,000 | Source |
| Lobbied for | Rights to Federally Funded Inventions and Licensing of Government Owned Inventions | Lobbied on march-in — matched LDA filing topic to Federal Register rule. | Source |